<abstract xmlns="http://www.w3.org/1999/xhtml"><p> Hospitalisation course and outcome for patients with extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae infection is less favourable due to extensive antibacterial resistance. This study was conducted to identify possible risk factors that could influence the hospitalisation course and outcome in these patients. The study protocol included demographic, clinical, hospitalisation, bacteriological and plasmid genetic data. The preliminary study results showed that hospitalisation course and outcome was less favourable for internal medicine profile patients with ESBL producing bacteria, TEM gene presence in the bacterial plasmid genome, patient age &lt; 65 years and patients with infectious and musculoskeletal diseases. The study includes preliminary data only and further studies should be carried out to verify the suggested risk factors.</p></abstract>

Hospitalisation course and outcome for patients with extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae infection is less favourable due to extensive antibacterial resistance. This study was conducted to identify possible risk factors that could influence the hospitalisation course and outcome in these patients. The study protocol included demographic, clinical, hospitalisation, bacteriological and plasmid genetic data. The preliminary study results showed that hospitalisation course and outcome was less favourable for internal medicine profile patients with ESBL producing bacteria, TEM gene presence in the bacterial plasmid genome, patient age < 65 years and patients with infectious and musculoskeletal diseases. The study includes preliminary data only and further studies should be carried out to verify the suggested risk factors.

Risk Factors that Determine Less Favourable Hospitalisation Course and Outcome in Patients with ESBL Producing Enterobacteriaceae Infection: Preliminary Results / Riska Faktori, Kas Nosaka Sliktāku Hospitalizācijas Gaitu Un Iznākumu Pacientiem Ar Esbl Producējošu Enterobacteriaceae Dzimtas Baktēriju Infekciju: Sākotnējie Rezultāti

Rīga East Clinical University Hospital, Hipokrāta iela 2, Rīga, LV-1038, LATVIA

Department of Internal Medicine, Rīga Stradiņš University, Dzirciema iela 16, Rīga, LV-1007, LATVIA

University of Latvia, Raiņa bulv. 19, Rīga, LV-1586, LATVIA

Scientific Laboratory of Molecular Genetics, Rīga Stradiņš University, Dzirciema iela 16, Rīga, LV-1007, LATVIA

Bacteriology Laboratory, Rīga East Clinical University Hospital, Hipokrāta iela 2, Rīga, LV-1038, LATVIA

Rīga East Clinical University Hospital, Hipokrča iela 2, Rīga, LV-1038, LATVIA

Department of Infectology and Dermatology, Rīga Stradiņš University, Dzirciema iela 16, Rīga, LV-1007, LATVIA

Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Hospitalisation course and outcome for patients with extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae infection is less favourable due to...

Publié en ligne: 04 août 2016

Pages: 252 - 255

Reçu: 12 mai 2016

DOI: https://doi.org/10.1515/prolas-2016-0025

Mots clés
Enterobacteriaceae, ESBL, hospitalization, TEM, SHV

© by Vita Skuja

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Publié en ligne: 04 août 2016

Pages: 252 - 255

Reçu: 12 mai 2016

DOI: https://doi.org/10.1515/prolas-2016-0025

Mots clésEnterobacteriaceae, ESBL, hospitalization, TEM, SHV

© by Vita Skuja

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Mots clés
Enterobacteriaceae, ESBL, hospitalization, TEM, SHV